Arnaud Pigneux

11.4k total citations · 1 hit paper
161 papers, 4.1k citations indexed

About

Arnaud Pigneux is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Arnaud Pigneux has authored 161 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Hematology, 47 papers in Public Health, Environmental and Occupational Health and 46 papers in Molecular Biology. Recurrent topics in Arnaud Pigneux's work include Acute Myeloid Leukemia Research (105 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Acute Lymphoblastic Leukemia research (46 papers). Arnaud Pigneux is often cited by papers focused on Acute Myeloid Leukemia Research (105 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Acute Lymphoblastic Leukemia research (46 papers). Arnaud Pigneux collaborates with scholars based in France, United States and Italy. Arnaud Pigneux's co-authors include Norbert Vey, Xavier Thomas, Stéphane de Botton, Christian Récher, Hervé Dombret, Daniel J. DeAngelo, Robert K. Stuart, Josy Reiffers, Nöel Milpied and Harry P. Erba and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Arnaud Pigneux

156 papers receiving 4.1k citations

Hit Papers

Acute myeloid leukemia ontogeny is defined by distinct so... 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
    2014 595 citations Arnaud Pigneux et al. Blood profile →

Peers

Arnaud Pigneux
Pierre W. Wijermans Netherlands
Stéphane de Botton France
Adriano Venditti Italy
Michael Rytting United States
Pau Montesinos Spain
F Zintl Germany
R Ohno Japan
Ollivier Legrand France
Dan Douer United States
Ursula Creutzig Germany
Pierre W. Wijermans Netherlands
Arnaud Pigneux
Citations per year, relative to Arnaud Pigneux Arnaud Pigneux (= 1×) peers Pierre W. Wijermans

Countries citing papers authored by Arnaud Pigneux

Since Specialization
Citations

This map shows the geographic impact of Arnaud Pigneux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Pigneux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Pigneux more than expected).

Fields of papers citing papers by Arnaud Pigneux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Pigneux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Pigneux. The network helps show where Arnaud Pigneux may publish in the future.

Co-authorship network of co-authors of Arnaud Pigneux

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Pigneux. A scholar is included among the top collaborators of Arnaud Pigneux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Pigneux. Arnaud Pigneux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Leroy, Harmony, Emilie Bérard, Isabelle Luquet, et al.. (2024). Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy. Cancer Medicine. 13(3). e7003–e7003. 1 indexed citations
3.
Duployez, Nicolas, Juliette Lambert, Maël Heiblig, et al.. (2023). Hyperleukocytosis Increases the Risk of Early Relapses Independently of Genetics in AML. Blood. 142(Supplement 1). 4322–4322.
4.
Socié, Gèrard, Pere Barba, Arie Barlev, et al.. (2023). Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. Bone Marrow Transplantation. 59(1). 52–58. 9 indexed citations
5.
Dumas, Pierre‐Yves, Arnaud Villacreces, Amélie V. Guitart, et al.. (2021). Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3 -ITD Acute Myeloid Leukemia. Clinical Cancer Research. 27(21). 6012–6025. 24 indexed citations
6.
Devillier, Raynier, Édouard Forcade, Alice Garnier, et al.. (2021). In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood Advances. 6(6). 1804–1812. 17 indexed citations
7.
Duployez, Nicolas, Matthieu Duchmann, Laëtitia Largeaud, et al.. (2021). Prognostic Significance of DDX41 Germline Mutations in Intensively Treated AML Patients: An ALFA-Filo Study. Blood. 138(Supplement 1). 612–612.
8.
Michallet, Mauricette, Mohamad Sobh, Gilbert Deray, et al.. (2020). Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts. Clinical Lymphoma Myeloma & Leukemia. 21(1). 35–45. 5 indexed citations
9.
Pollyea, Daniel A., Courtney D. DiNardo, Martha Arellano, et al.. (2020). Results of Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Acute Myeloid Leukemia with IDH 1/2 Mutations. Blood. 136(Supplement 1). 5–7. 27 indexed citations
10.
Dumas, Pierre‐Yves, Sarah Bertoli, Emilie Bérard, et al.. (2020). Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers. 12(8). 2044–2044. 5 indexed citations
11.
12.
Huguet, Françoise, Thibaut Leguay, Emmanuel Raffoux, et al.. (2014). Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup. Leukemia & lymphoma. 56(4). 847–857. 20 indexed citations
13.
Nerich, Virginie, Bruno Lioure, Christian Récher, et al.. (2011). Induction-related cost of patients with acute myeloid leukaemia in France. International Journal of Clinical Pharmacy. 33(2). 191–199. 17 indexed citations
14.
Pigneux, Arnaud, Jean‐Luc Harousseau, Francis Witz, et al.. (2010). Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS. Journal of Clinical Oncology. 28(18). 3028–3034. 26 indexed citations
15.
Pigneux, Arnaud, M-L. Tanguy, Mauricette Michallet, et al.. (2002). Prior treatment with alpha interferon does not adversely 
affect the outcome of allogeneic transplantation 
for chronic myeloid leukaemia. British Journal of Haematology. 116(1). 193–201. 15 indexed citations
16.
Pigneux, Arnaud, et al.. (2000). Effect of Antisense Oligonucleotides on CD34+ Cells from Chronic Myeloid Leukemia. Leukemia & lymphoma. 36(5-6). 569–578. 3 indexed citations
17.
Hilbert, Gilles, Didier Gruson, Frédéric Vargas, et al.. (2000). Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Critical Care Medicine. 28(9). 3185–3190. 76 indexed citations
18.
Mahon, François Xavier, Gérald Marit, Jean-Michel Boiron, et al.. (1998). Autologous Stem Cell Transplantation for Chronic Myeloid Leukemia. Recent results in cancer research. 144. 8–14. 2 indexed citations
19.
20.
Pigneux, Arnaud, A Devergié, E Archimbaud, et al.. (1995). Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle.. PubMed. 15(6). 819–24. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre W. Wijermans Breakdown of academic impact, for papers by Stéphane de Botton Breakdown of academic impact, for papers by Adriano Venditti Breakdown of academic impact, for papers by Michael Rytting Breakdown of academic impact, for papers by Pau Montesinos Breakdown of academic impact, for papers by F Zintl Breakdown of academic impact, for papers by R Ohno Breakdown of academic impact, for papers by Ollivier Legrand Breakdown of academic impact, for papers by Dan Douer Breakdown of academic impact, for papers by Ursula Creutzig
Rankless by CCL
2026